<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To study the FLT3 gene expression and its internal tandem duplication in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> and its clinical significance, polymerase chain reaction (PCR) and DNA sequencing were used to detect the FLT3/ITD mutation in blast cells of bone marrow from 86 patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, including 32 cases of <z:hpo ids='HP_0011009'>acute</z:hpo> myeoloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), 18 cases of <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), 2 cases of <z:hpo ids='HP_0011009'>acute</z:hpo> hybrid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AHL</z:e>), 12 cases of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 10 cases of <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 3 cases of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) and 9 cases of <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM) </plain></SENT>
<SENT sid="1" pm="."><plain>The resultes showed that the expression of FLT3/ITD gene could be detected in 5 of 32 (15.6%) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients, including 1/7 of M(3), 1/10 of M(4) and 3/10 of M(5) </plain></SENT>
<SENT sid="2" pm="."><plain>More FLT3 aberrations were found in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M(5) </plain></SENT>
<SENT sid="3" pm="."><plain>No FLT3/ITD was found in 18 cases of ALL, in 2 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AHL</z:e>, in 12 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and in 10 cases of <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>No FLT3 was found in 3 cases of NHL and in 9 cases of MM </plain></SENT>
<SENT sid="5" pm="."><plain>Sequence analysis in 2 case with abnormal PCR electrophoretic patterns revealed that the ITDs were located within exon 14 from 27 to 63 bp, which was a simple tandem duplication, and did not altered the reading frame </plain></SENT>
<SENT sid="6" pm="."><plain>FLT3/ITD was associated with a higher peripheral blood white cell count (p &lt; 0.01), higher percentage of bone marrow blast cells (p &lt; 0.01) and lower complete mission rate </plain></SENT>
<SENT sid="7" pm="."><plain>It is concluded that more FLT3/ITD mutation occurs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M(5) patients </plain></SENT>
<SENT sid="8" pm="."><plain>Sequence of the mutants is in frame mutation </plain></SENT>
<SENT sid="9" pm="."><plain>FLT3/ITD mutation is associated with higher peripheral blood white cell count, higher percentage of bone marrow blast cells and lower complete remission rate, FIT3/IID gene mutation may be used to predict prognosis of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>